HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

Yasuto Yoneshima; Koji Kato; Haruna Minami; Munehiko Ikeda; Hiroyuki Watanabe; Goichi Yoshimoto; Toshihiro Miyamoto; Koichi Akashi; Yoichi Nakanishi; Isamu Okamoto

doi:10.1111/cas.14536

HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

Yasuto Yoneshima, Koji Kato, Haruna Minami, Munehiko Ikeda, Hiroyuki Watanabe, Goichi Yoshimoto, Toshihiro Miyamoto, Koichi Akashi, Yoichi Nakanishi, Isamu Okamoto

研究成果: ジャーナルへの寄稿 › レター › 査読

2 被引用数 (Scopus)

本文言語	英語
ページ（範囲）	3395-3396
ページ数	2
ジャーナル	Cancer Science
巻	111
号	9
DOI	https://doi.org/10.1111/cas.14536
出版ステータス	出版済み - 9月 1 2020

!!!All Science Journal Classification (ASJC) codes

腫瘍学
癌研究

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1111/cas.14536

他のファイルとリンク

引用スタイル

@article{73a98d4e747c44a69327c7b064262888,

title = "HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors",

author = "Yasuto Yoneshima and Koji Kato and Haruna Minami and Munehiko Ikeda and Hiroyuki Watanabe and Goichi Yoshimoto and Toshihiro Miyamoto and Koichi Akashi and Yoichi Nakanishi and Isamu Okamoto",

year = "2020",

month = sep,

day = "1",

doi = "10.1111/cas.14536",

language = "English",

volume = "111",

pages = "3395--3396",

journal = "Cancer Science",

issn = "1347-9032",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors

AU - Yoneshima, Yasuto

AU - Kato, Koji

AU - Minami, Haruna

AU - Ikeda, Munehiko

AU - Watanabe, Hiroyuki

AU - Yoshimoto, Goichi

AU - Miyamoto, Toshihiro

AU - Akashi, Koichi

AU - Nakanishi, Yoichi

AU - Okamoto, Isamu

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85088147097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088147097&partnerID=8YFLogxK

U2 - 10.1111/cas.14536

DO - 10.1111/cas.14536

M3 - Letter

C2 - 32557883

AN - SCOPUS:85088147097

SN - 1347-9032

VL - 111

SP - 3395

EP - 3396

JO - Cancer Science

JF - Cancer Science

IS - 9

ER -